Chemoinformaics analysis of ?-glutamyl peptide
Molecular Weight | 130.123 | nRot | 4 |
Heavy Atom Molecular Weight | 122.059 | nRig | 2 |
Exact Molecular Weight | 130.05 | nRing | 0 |
Solubility: LogS | -0.613 | nHRing | 0 |
Solubility: LogP | -3.043 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 17.1903 |
nHD | 2 | BPOL | 9.19166 |
QED | 0.526 |
Synth | 3.59 |
Natural Product Likeliness | 0.988 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.072 |
HIA | 0.021 |
CACO-2 | -5.832 |
MDCK | 0.00392831 |
BBB | 0.176 |
PPB | 0.185712 |
VDSS | 0.415 |
FU | 0.854586 |
CYP1A2-inh | 0.009 |
CYP1A2-sub | 0.045 |
CYP2c19-inh | 0.044 |
CYP2c19-sub | 0.053 |
CYP2c9-inh | 0.035 |
CYP2c9-sub | 0.24 |
CYP2d6-inh | 0.036 |
CYP2d6-sub | 0.244 |
CYP3a4-inh | 0.011 |
CYP3a4-sub | 0.031 |
CL | 9.5 |
T12 | 0.751 |
hERG | 0.018 |
Ames | 0.351 |
ROA | 0.038 |
SkinSen | 0.384 |
Carcinogencity | 0.03 |
EI | 0.163 |
Respiratory | 0.208 |
NR-Aromatase | 0.008 |
Antiviral | No |
Prediction | 0.957879 |